Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
Authors:
Open Access
- 30 August 2005
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 93 (6) , 627-632
Abstract
The purpose of this study was to examine the effect on survival of delaying the start of adjuvant chemotherapy for early breast cancer for up to 3 months after surgery. In the nation-wide clinical trials of the Danish Breast Cancer Cooperative Group, 7501 breast cancer patients received chemotherapy within 3 months of surgery between 1977 and 1999: 352 with classical cyclofosfamide, metotrexate and 5-fluorouracil (CMF); 6065 with CMF i.v. and 1084 with cyclofosfamide, epirubicin and 5-fluorouracil. For the analysis, the time between surgery and the start of chemotherapy was divided into four strata (1-3, 4, 5 and 6-13 weeks). The results show that within the three groups of chemotherapy, there was an even distribution of known prognostic factors across the four strata of initiation of chemotherapy. There was no pattern indicating a benefit from early start of chemotherapy. No significant interactions were found for subgroups of patients with a poorer prognosis (many involved lymph nodes, high-grade malignancies or hormone receptor negative disease). In conclusion, we have found no evidence for a survival benefit due to early initiation of adjuvant chemotherapy within the first 2-3 months after surgery.Keywords
This publication has 16 references indexed in Scilit:
- Does Timing of Adjuvant Chemotherapy for Early Breast Cancer Influence Survival?Journal of Clinical Oncology, 2003
- International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and RecommendationsJournal of Clinical Oncology, 2003
- Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18Journal of the National Cancer Institute Monographs, 2001
- Improved survival after one course of perioperative chemotherapy in early breast cancer patientsEuropean Journal of Cancer, 2001
- Is there a range of time for initiation of adjuvant chemotherapy in patients with malignancy?Annals of Oncology, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Impact of Administration-Related Factors on Outcome of Adjuvant Chemotherapy for Primary Breast CancerAmerican Journal of Clinical Oncology, 1989
- Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancerBreast Cancer Research and Treatment, 1982